I think we're in the early innings of what will become an evolving set of tools that many innovator drug companies may engage with to protect their assets, and this runs completely counter to the objectives of competition for biosimilars or for other innovative products.
Highlighting concerns about drug companies using legal strategies to hinder competition.
Share
More from Susan Collins
I think what happened is far too many ICE officers were hired and deployed without adequate vetting and training. But let us not forget the important work that ICE does, which is why it should be reformed and not abolished, as Troy has…
I am pleased that these funds are being released to help Mainers afford to heat their homes this winter without having to choose between staying warm and paying for other basic necessities.
Other voices in this conversation
